Technology
Health
Medical

SurModics

$41.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.51 (-1.22%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SurModics and other stocks, options, ETFs, and crypto commission-free!

About

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. Read More The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Employees
338
Headquarters
Eden Prairie, Minnesota
Founded
1979
Market Cap
563.15M
Price-Earnings Ratio
β€”
Dividend Yield
β€”
Average Volume
96.70K
High Today
$41.89
Low Today
$40.01
Open Price
$41.61
Volume
59.75K
52 Week High
$82.35
52 Week Low
$34.06

Collections

Technology
Health
Medical
Healthcare
Medical Devices
US
North America

News

TradingNewsNowMar 22

Recent Valuation: Surmodics (NASDAQ: SRDX)

Surmodics is part of the medical diagnostics and research industry and healthcare sector. Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. Previous Intraday Trading Performance: The SRDX stock showed a previous change of 2.55% with an open at 44.62 and a close of 45.87. It reached an intraday high of 46.56 and a low of 44.46. SeekingAlpha: Surmodics down 8% on risk to SurVeil DCB study Liquidity: The stock has a market cap of $618.4m w...

11
Simply Wall StMar 8

Before You Buy Surmodics, Inc. (NASDAQ:SRDX), Consider Its Volatility

If you own shares in Surmodics, Inc. (NASDAQ:SRDX) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first type is company specific volatility. Investors use diversification across uncorrelated stocks to reduce this kind of price volatility across the portfolio. The other type, which cannot be dive...

30
TradingNewsNowMar 1

Present Movement: Surmodics (NASDAQ: SRDX)

Surmodics trades as part of the healthcare sector and medical diagnostics and research industry. The company CEO is Gary Maharaj. Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. Previous Intraday Trading Performance: The SRDX stock showed a previous change of 1.76% with an open at 57.09 and a close of 58.35. It reached an intraday high of 58.52 and a low of 57.09. SeekingAlpha: Surmodics announces appointment of Timothy J. Arens as CFO ...

0

Earnings

-$0.24
-$0.07
$0.10
$0.27
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.